who was the one that discovered it?
Harvey J. Alter.
Hepatitis C
In the mid-1970s, Harvey J. Alter, Chief of the Infectious Disease Section in the Department of Transfusion Medicine at the National Institutes of Health, and his research team demonstrated how most post-transfusion hepatitis cases were not due to hepatitis A or B viruses. Despite this discovery, international research efforts to identify the virus, initially called "non-A, non-B hepatitis" (NANBH), failed for the next decade. In 1987, Michael Houghton, Qui-Lim Choo, and George Kuo at Chiron Corporation, collaborating with Daniel W. Bradley at the Centers for Disease Control and Prevention, used a novel molecular cloning approach to identify the unknown organism and develop a diagnostic test. In 1988, Alter confirmed the virus by verifying its presence in a panel of NANBH specimens.
when was the cure for hep c found There is no vaccine against hepatitis C. Chronic infection can be cured more than 95% of the time with antiviral medications such as sofosbuvir or simeprevir. what is hep c? It is an infectious disease caused by the hepatitis C virus that primarily affects the liver; it is a type of viral hepatitis. does it happen due to intercourse too? Sexual transmission of hepatitis C is uncommon. describe how is it transmitted? The primary route of transmission in the developed world is injection drug use, while in the developing world the main methods are blood transfusions and unsafe medical procedures. how was it discovered? Researchers used a novel molecular cloning approach to identify the unknown organism and develop a diagnostic test. how is it related to pregnancy? It is not clear when transmission occurs during pregnancy, but it may occur both during gestation and at delivery. A long labor is associated with a greater risk of transmission. There is no evidence that breastfeeding spreads HCV.
wiki:13485162
Hepatitis C [SEP] History
In the mid-1970s, Harvey J. Alter, Chief of the Infectious Disease Section in the Department of Transfusion Medicine at the National Institutes of Health, and his research team demonstrated how most post-transfusion hepatitis cases were not due to hepatitis A or B viruses. Despite this discovery, international research efforts to identify the virus, initially called "non-A, non-B hepatitis" (NANBH), failed for the next decade. In 1987, Michael Houghton, Qui-Lim Choo, and George Kuo at Chiron Corporation, collaborating with Daniel W. Bradley at the Centers for Disease Control and Prevention, used a novel molecular cloning approach to identify the unknown organism and develop a diagnostic test.